NCT00359476View on ClinicalTrials.gov

A Study of Vinflunine in Patients With Gastric Cancer

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Stomach Cancer
Interventions
DRUG

Vinflunine

solution for injection, IV, 280/320 mg/m2, every 3 wks, variable duration

Trial Locations (6)

1102

Local Institution, Quezon City

71800

Local Institution, Kampung Baharu Nilai

442-723

Local Institution, Suwon

410-769

Local Institution, Gyeonggi-do

120-752

Local Institution, Seoul

136-705

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY